Humana Inc (HUM) SVP Jody L. Bilney Sells 7,054 Shares of Stock
Humana Inc (NYSE:HUM) SVP Jody L. Bilney sold 7,054 shares of the company’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $247.89, for a total value of $1,748,616.06. Following the sale, the senior vice president now directly owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Humana Inc (HUM) opened at $245.16 on Wednesday. The company has a market capitalization of $35,197.87, a price-to-earnings ratio of 21.02, a P/E/G ratio of 1.69 and a beta of 0.88. Humana Inc has a 12-month low of $186.25 and a 12-month high of $264.56. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. During the same period in the prior year, the company posted $3.18 earnings per share. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. analysts predict that Humana Inc will post 11.63 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.65%. Humana’s dividend payout ratio is currently 12.59%.
A number of institutional investors have recently added to or reduced their stakes in the business. Parametric Portfolio Associates LLC raised its stake in Humana by 11.9% during the third quarter. Parametric Portfolio Associates LLC now owns 451,212 shares of the insurance provider’s stock worth $109,929,000 after acquiring an additional 47,987 shares in the last quarter. AXA raised its stake in Humana by 24.2% during the third quarter. AXA now owns 34,900 shares of the insurance provider’s stock worth $8,503,000 after acquiring an additional 6,800 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in Humana by 2.4% during the third quarter. Public Employees Retirement System of Ohio now owns 98,701 shares of the insurance provider’s stock worth $24,047,000 after acquiring an additional 2,348 shares in the last quarter. GSA Capital Partners LLP raised its stake in Humana by 159.3% during the third quarter. GSA Capital Partners LLP now owns 10,111 shares of the insurance provider’s stock worth $2,463,000 after acquiring an additional 6,211 shares in the last quarter. Finally, Archford Capital Strategies LLC raised its stake in Humana by 22,823.5% during the third quarter. Archford Capital Strategies LLC now owns 3,897 shares of the insurance provider’s stock worth $949,000 after acquiring an additional 3,880 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.
A number of equities research analysts have issued reports on the company. ValuEngine cut Humana from a “buy” rating to a “hold” rating in a research report on Tuesday. Credit Suisse Group assumed coverage on Humana in a research report on Thursday, November 2nd. They set a “neutral” rating and a $256.00 target price for the company. Zacks Investment Research cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Morgan Stanley reduced their price objective on Humana from $276.00 to $270.00 and set an “overweight” rating for the company in a research report on Thursday, November 9th. Finally, Cowen reissued a “buy” rating and issued a $285.00 price objective on shares of Humana in a research report on Wednesday, December 13th. Twelve equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $256.30.
COPYRIGHT VIOLATION NOTICE: “Humana Inc (HUM) SVP Jody L. Bilney Sells 7,054 Shares of Stock” was published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.watchlistnews.com/humana-inc-hum-svp-jody-l-bilney-sells-7054-shares-of-stock/1774570.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.